HOME >> MEDICINE >> NEWS
Lupus Foundation Of America Awards Summer Internship To Student Working At Wistar Institute

PHILADELPHIA, Penn. -- Su-jean Seo, a native of Corbin, Kentucky, has been awarded the Lupus Foundation of America's Gina Finzi Memorial Student Summer Fellowship for a research project she is conducting at The Wistar Institute.

The fellowship was designed to encourage young scientists to participate in lupus related research under the supervision of an established scientific investigator. It will support Ms. Seo's work in Dr. Jan Erikson's laboratory in Wistar's Tumor Immunology Program.

Ms. Seo graduated cum laude from Yale University with a B.S. degree in molecular biophysics and biochemistry. During her junior and senior years, she worked as a research assistant in the Section of Neurobiology at Yale University's School of Medicine. Her specific project was on the "generation of a monoclonal antibody against a breast adenocarcinoma specific antigen."

Ms. Seo is currently enrolled in a joint Ph.D./M.D. degree program at the University of Pennsylvania. She is doing her graduate rotation at Wistar, where her research focuses on antigens targeted in autoimmune diseases such as lupus erythematosus.

Following her graduation, Ms. Seo hopes to combine clinical practice with research in immunology.

The Wistar Institute, established in 1892, was the first independent medical research facility in the country. For more than 100 years, Wistar scientists have been making history and improving world health through their development of vaccines for diseases that include rabies, German measles, infantile gastroenteritis (rotavirus), and cytomegalovirus; discovery of molecules like interleukin-12, which are helping the immune system fight bacteria, parasites, viruses and cancer; and location of genes that contribute to the development of diseases like breast, lung and prostate cancer. Wistar is a National Cancer Institute Cancer Center.


'"/>

Contact: Diana Cutshall
dcutshall@wista.wistar.upenn.edu
(215) 898-3716
The Wistar Institute
7-Jul-1998


Page: 1

Related medicine news :

1. Lupus discovery may pave way to better-designed COX-2 inhibitors
2. Lupus Today: Research into Action
3. Hopkins Researchers Develop New Therapy For Autoimmune Disorders Such As Rheumatoid Arthritis And Lupus
4. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
5. Top honor for head of Epilepsy Foundation
6. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
7. Prentiss Foundation awards $5 million to University Hospitals
8. Endocrine Society and Hormone Foundation call for increased research
9. Foundation to honor physicians and community health initiatives around the world
10. Donald W. Reynolds Foundation awards UT Southwestern $12 million to continue Dallas Heart Study
11. NYU Child Study Center and The Bear Stearns Charitable Foundation launch outreach campaign

Post Your Comments:
(Date:3/6/2015)... Protein identification is increasingly being ... science research including drug discovery, diagnostics, immunology and ... was valued at $1,569.00 million in 2014 and ... 10.63% to reach $2,600.28 million in 2019. , ... protein based on protein size, shape, sequence and ...
(Date:3/6/2015)... As healthcare providers create one ... from disparate systems, they are using OnBase by ... efficiency. Enterprise content management (ECM) solutions ... IT solutions, including electronic medical records (EMR), enterprise ... , The following organizations have recently integrated ...
(Date:3/6/2015)... March 06, 2015 Saving Moses, a ... the world is traveling to Angola, Africa March 7-14 ... their malnutrition program. , This will be the organizations ... Angola, demonstrating their commitment to the region’s population by ... team will engage with the mothers and babies of ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2
(Date:3/6/2015)... , March 6, 2015  Palatin Technologies, Inc. (NYSE MKT: ... 27 th Annual ROTH Conference on Wednesday, March 11, ... held at the Ritz Carlton Laguna Niguel in ... Spana , Ph.D., President and Chief Executive Officer of Palatin ... programs. About Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Hospira, Inc. ... Food and Drug Administration (FDA) on today,s FDA approval of ... . This is a watershed moment for improving patient access ... leading global provider of biosimilars, Hospira has seen first-hand the ... a proud participant in these early stages of the development ...
(Date:3/6/2015)... March 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the ... diseases and cancer, today announced that James A. ... present a corporate overview at the 27th Annual ROTH ... time.  Aethlon was previously scheduled to present at 5:30 ... will be held at The Ritz-Carlton Hotel in ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
Cached News: